Market Cap: $1.17B
Filed a patent for "dosing regimens for cancer immunotherapy" on Tue, November 7, 2023
Filed a patent for "dosage regimens for parp7 inhibitors" on Thu, October 3, 2024
Filed a patent for "use of maribavir in treatment regimens" on Thu, May 16, 2024
Filed a patent for "methods and apparatus utilising liquid biopsy to identify and monitor pharmacodynamic markers of disease" on Thu, June 20, 2024
